
This episode discusses a systematic review on intrathecal adjuvants used during cesarean delivery and their effects on pain relief and recovery.
In this episode, we unpack a massive 2026 systematic review and network meta-analysis covering nearly 15,000 patients and 166 clinical trials on intrathecal adjuvants used during cesarean delivery. From morphine and dexmedetomidine to fentanyl combinations and off-label spinal agents, we explore which medications truly extend pain relief, reduce opioid use, and improve recovery, without increasing serious side effects. What does the evidence actually support, and where does uncertainty still remain? Read more about this study HERE . ====================================== Where else to find us: Web - https://www.nysora.com/ Instagram - instagram.com/nysora.inc/ LinkedIn - linkedin.com/company/nysora-inc/ Facebook - facebook.com/nysora Twitter - x.com/nysora TikTok - tiktok.com/@nysora_inc --------------------------------------------------------- #nysora #regionalanesthesia #anesthesia Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are…
Host: NYSORA
Organizations: NYSORA
Products: morphine, dexmedetomidine, fentanyl, intrathecal adjuvants
Places: cesarean delivery
Explore listener stats, chart rankings, contacts and more on the Anesthesia Updates podcast page.